Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Essex Bio-Technology ( (HK:1061) ) just unveiled an announcement.
Essex Bio-Technology Limited has announced a board meeting scheduled for March 26, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the payment of a final dividend, which could impact the company’s financial strategy and shareholder returns.
More about Essex Bio-Technology
Essex Bio-Technology Limited is a company incorporated in the Cayman Islands, operating in the biotechnology industry. The company focuses on developing and commercializing biopharmaceutical products, with a market emphasis on ophthalmology and dermatology.
YTD Price Performance: -6.12%
Average Trading Volume: 312,381
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$1.57B
See more insights into 1061 stock on TipRanks’ Stock Analysis page.